Aptose Biosciences Stock Net Income
| APS Stock | CAD 2.26 0.01 0.44% |
As of the 15th of February 2026, Aptose Biosciences shows the Downside Deviation of 2.99, risk adjusted performance of 0.095, and Mean Deviation of 1.94. Aptose Biosciences technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.
Aptose Biosciences Total Revenue |
|
| Last Reported | Projected for Next Year | ||
| Net Loss | -22.9 M | -24 M | |
| Net Loss | -22.9 M | -24 M | |
| Net Loss | -37.6 M | -39.5 M | |
| Net Loss | (5.15) | (5.41) |
Aptose | Net Income |
Evaluating Aptose Biosciences's Net Income across multiple reporting periods reveals the company's ability to sustain growth and manage resources effectively. This longitudinal analysis highlights inflection points, cyclical patterns, and structural changes that short-term snapshots might miss, offering deeper insight into Aptose Biosciences's fundamental strength.
Latest Aptose Biosciences' Net Income Growth Pattern
Below is the plot of the Net Income of Aptose Biosciences over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in Aptose Biosciences financial statement analysis. It represents the amount of money remaining after all of Aptose Biosciences operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is Aptose Biosciences' Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Aptose Biosciences' overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported (25.43 M) | 10 Years Trend |
|
Net Income |
| Timeline |
Aptose Net Income Regression Statistics
| Arithmetic Mean | (23,276,546) | |
| Coefficient Of Variation | (85.13) | |
| Mean Deviation | 15,531,292 | |
| Median | (22,887,000) | |
| Standard Deviation | 19,814,802 | |
| Sample Variance | 392.6T | |
| Range | 65.3M | |
| R-Value | (0.67) | |
| Mean Square Error | 230.9T | |
| R-Squared | 0.45 | |
| Significance | 0 | |
| Slope | (2,628,248) | |
| Total Sum of Squares | 6282T |
Aptose Net Income History
Aptose Net Income Driver Correlations
Understanding the fundamental principles of building solid financial models for Aptose Biosciences is extremely important. It helps to project a fair market value of Aptose Stock properly, considering its historical fundamentals such as Net Income. Since Aptose Biosciences' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Aptose Biosciences' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Aptose Biosciences' interrelated accounts and indicators.
Click cells to compare fundamentals
Aptose Biosciences 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Aptose Biosciences' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Aptose Biosciences.
| 11/17/2025 |
| 02/15/2026 |
If you would invest 0.00 in Aptose Biosciences on November 17, 2025 and sell it all today you would earn a total of 0.00 from holding Aptose Biosciences or generate 0.0% return on investment in Aptose Biosciences over 90 days. Aptose Biosciences is related to or competes with Senvest Capital, Bank of Montreal, Bank of Montreal, Royal Bank, Royal Bank, and National Bank. Aptose Biosciences Inc., a clinical-stage biotechnology company, discovers and develops personalized therapies addressin... More
Aptose Biosciences Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Aptose Biosciences' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Aptose Biosciences upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 2.99 | |||
| Information Ratio | 0.0836 | |||
| Maximum Drawdown | 14.67 | |||
| Value At Risk | (4.29) | |||
| Potential Upside | 5.36 |
Aptose Biosciences Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Aptose Biosciences' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Aptose Biosciences' standard deviation. In reality, there are many statistical measures that can use Aptose Biosciences historical prices to predict the future Aptose Biosciences' volatility.| Risk Adjusted Performance | 0.095 | |||
| Jensen Alpha | 0.337 | |||
| Total Risk Alpha | 0.0856 | |||
| Sortino Ratio | 0.0771 | |||
| Treynor Ratio | (0.37) |
Aptose Biosciences February 15, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.095 | |||
| Market Risk Adjusted Performance | (0.36) | |||
| Mean Deviation | 1.94 | |||
| Semi Deviation | 2.25 | |||
| Downside Deviation | 2.99 | |||
| Coefficient Of Variation | 917.35 | |||
| Standard Deviation | 2.75 | |||
| Variance | 7.58 | |||
| Information Ratio | 0.0836 | |||
| Jensen Alpha | 0.337 | |||
| Total Risk Alpha | 0.0856 | |||
| Sortino Ratio | 0.0771 | |||
| Treynor Ratio | (0.37) | |||
| Maximum Drawdown | 14.67 | |||
| Value At Risk | (4.29) | |||
| Potential Upside | 5.36 | |||
| Downside Variance | 8.93 | |||
| Semi Variance | 5.05 | |||
| Expected Short fall | (2.44) | |||
| Skewness | 0.5133 | |||
| Kurtosis | 1.47 |
Aptose Biosciences Backtested Returns
As of now, Aptose Stock is risky. Aptose Biosciences secures Sharpe Ratio (or Efficiency) of 0.0697, which signifies that the company had a 0.0697 % return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Aptose Biosciences, which you can use to evaluate the volatility of the firm. Please confirm Aptose Biosciences' Mean Deviation of 1.94, downside deviation of 2.99, and Risk Adjusted Performance of 0.095 to double-check if the risk estimate we provide is consistent with the expected return of 0.19%. Aptose Biosciences has a performance score of 5 on a scale of 0 to 100. The firm shows a Beta (market volatility) of -0.78, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Aptose Biosciences are expected to decrease at a much lower rate. During the bear market, Aptose Biosciences is likely to outperform the market. Aptose Biosciences right now shows a risk of 2.75%. Please confirm Aptose Biosciences semi variance, and the relationship between the maximum drawdown and accumulation distribution , to decide if Aptose Biosciences will be following its price patterns.
Auto-correlation | -0.23 |
Weak reverse predictability
Aptose Biosciences has weak reverse predictability. Overlapping area represents the amount of predictability between Aptose Biosciences time series from 17th of November 2025 to 1st of January 2026 and 1st of January 2026 to 15th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Aptose Biosciences price movement. The serial correlation of -0.23 indicates that over 23.0% of current Aptose Biosciences price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.23 | |
| Spearman Rank Test | -0.54 | |
| Residual Average | 0.0 | |
| Price Variance | 0.01 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Aptose Accumulated Other Comprehensive Income
Accumulated Other Comprehensive Income |
|
Based on the recorded statements, Aptose Biosciences reported net income of (25.43 Million). This is 107.45% lower than that of the Biotechnology sector and 136.3% lower than that of the Health Care industry. The net income for all Canada stocks is 104.45% higher than that of the company.
Aptose Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Aptose Biosciences' direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Aptose Biosciences could also be used in its relative valuation, which is a method of valuing Aptose Biosciences by comparing valuation metrics of similar companies.Aptose Biosciences is currently under evaluation in net income category among its peers.
Aptose Fundamentals
| Return On Equity | -6.94 | ||||
| Return On Asset | -1.41 | ||||
| Current Valuation | 30.82 M | ||||
| Shares Outstanding | 2.55 M | ||||
| Shares Owned By Insiders | 20.24 % | ||||
| Shares Owned By Institutions | 3.91 % | ||||
| Number Of Shares Shorted | 140 | ||||
| Price To Earning | (1.85) X | ||||
| Price To Book | 68.22 X | ||||
| EBITDA | (26.23 M) | ||||
| Net Income | (25.43 M) | ||||
| Cash And Equivalents | 36.37 M | ||||
| Cash Per Share | 0.64 X | ||||
| Total Debt | 10.64 M | ||||
| Debt To Equity | 5.00 % | ||||
| Current Ratio | 11.27 X | ||||
| Book Value Per Share | (10.38) X | ||||
| Cash Flow From Operations | (35.98 M) | ||||
| Short Ratio | 0.07 X | ||||
| Earnings Per Share | 0.94 X | ||||
| Target Price | 2.32 | ||||
| Number Of Employees | 13 | ||||
| Beta | 0.59 | ||||
| Market Capitalization | 5.77 M | ||||
| Total Asset | 10.13 M | ||||
| Retained Earnings | (540.97 M) | ||||
| Working Capital | 5.07 M | ||||
| Net Asset | 10.13 M |
About Aptose Biosciences Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Aptose Biosciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Aptose Biosciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Aptose Biosciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Aptose Biosciences
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Aptose Biosciences position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aptose Biosciences will appreciate offsetting losses from the drop in the long position's value.Moving against Aptose Stock
| 0.42 | NVDA | NVIDIA CDR | PairCorr |
| 0.42 | NVDA | Nvidia CDR | PairCorr |
| 0.34 | MSFT | Microsoft Corp CDR | PairCorr |
| 0.34 | MSFT | Microsoft CDR | PairCorr |
| 0.31 | AMZN | Amazon CDR | PairCorr |
The ability to find closely correlated positions to Aptose Biosciences could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Aptose Biosciences when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Aptose Biosciences - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Aptose Biosciences to buy it.
The correlation of Aptose Biosciences is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Aptose Biosciences moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Aptose Biosciences moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Aptose Biosciences can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Other Information on Investing in Aptose Stock
Aptose Biosciences financial ratios help investors to determine whether Aptose Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Aptose with respect to the benefits of owning Aptose Biosciences security.